Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Protalix Biotherapeutics Inc V.PLX.H


Primary Symbol: PLX

Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. In addition, the Company is developing PEGylated uricase, or PRX-115, for the treatment of severe gout, Long Acting (LA) DNase I, or PRX-119, for the treatment of NETs-related diseases, and other technologies and preclinical assets. Its product, Elelyso is an enzyme replacement therapy (ERT) for the treatment of patients with Gaucher disease. Its ProCellEx platform is being used to manufacture both of its approved and marketed products as well as PRX-115 and PRX-119. PRX-115, a plant cell-expressed recombinant PEGylated Uricase (urate oxidase)- a chemically modified enzyme under development for the potential treatment of severe gout. PRX-119 is a plant cell-expressed PEGylated recombinant human DNase I product candidate.


NYSEAM:PLX - Post by User

Comment by oilinvestor52on Jun 24, 2019 2:25pm
92 Views
Post# 29857021

RE:RE:Bruce Mitchell

RE:RE:Bruce MitchellThanks, porrter: is this the correct Bruce Mitchell?

Bruce H. Mitchell (born 1946) is a Canadian business executive. He is President and Chief Executive Officer of Permian Industries Limited, a Toronto-based management and holding company with interests in the North American food processing, technology and water purification industries.[1] Permian's wholly owned subsidiaries include Ajax Precision Manufacturing Ltd., a manufacturer of metal stampings and assemblies for the North American automobile industry; Trophy Foods, Inc., one of Canada's largest processors and distributors of edible nuts and related products; and Integrated Solutions Groups, Inc., a technology services and computer hardware provider operating in the U.S. Midwest. In total, Permian employs approximately 1,000 people at its 15 locations in North America.[2]

Mitchell is also Vice-Chair of the Board of Trustees and a Councillor of Queen's University, Vice-Chair of the Canadian Institute for Advanced Research and has served on the Board and executive committees of Ridley College and UNICEF Canada.

Mitchell served on the board of directors of: CFM CorporationGarbell Holdings LimitedGSW Inc and the Bank of Montreal. His total compensation from the Bank of Montreal in 2010 was $483,152.00[3][4]

Mitchell holds a B.Sc. (Civil Engineering) from Queen's University and an M.B.A. from Harvard University.[5]

He previously served as the chairman of Promanad Communications Inc. and Corvair Oils Ltd., and was president of The Toronto Golf Club. In 2018 he was Captain of the Royal and Ancient Golf Club - the first Canadian to hold the office.[6]

<< Previous
Bullboard Posts
Next >>